Bagalanon, Junald M.

HRN: 28-15-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2025
CEFTRIAXONE 1G (VIAL)
11/23/2025
11/29/2025
IV
2g
Q 24H
Multiple Gaping Wounds, Right Upper Extremity
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Compliant To Guidelines